Oops!
This page cannot be found.
See other information:

Stay informed
Learn more about CRYSVITA, connect with a support community, and receive invites to important educational events.

See other information:
Learn more about CRYSVITA, connect with a support community, and receive invites to important educational events.
CRYSVITA is a prescription medicine used to treat adults and children 2 years of age and older with fibroblast growth factor 23 (FGF23)–related hypophosphatemia in tumor-induced osteomalacia (TIO) when the tumor cannot be located or removed.
You should not take CRYSVITA if:
What is the most important information you should know about CRYSVITA?
What are the possible side effects of CRYSVITA?
Adverse reactions that were seen in adults with TIO are:
What is the most important information you should know about CRYSVITA?
What are the possible side effects of CRYSVITA?
Adverse reactions that were seen in adults with TIO are:
Before taking CRYSVITA, tell your doctor about all of your medications (including supplements) and medical conditions, including if you:
While taking CRYSVITA, tell your doctor if you experience:
These are not all the possible side effects of CRYSVITA. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Kyowa Kirin, Inc. at 1-844-768-3544.
For important risk and use information, please see the full Prescribing Information for CRYSVITA.
Before taking CRYSVITA, tell your doctor about all of your medications (including supplements) and medical conditions, including if you:
While taking CRYSVITA, tell your doctor if you experience:
These are not all the possible side effects of CRYSVITA. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Kyowa Kirin, Inc. at 1-844-768-3544.
For important risk and use information, please see the full Prescribing Information for CRYSVITA.
CRYSVITA is a prescription medicine used to treat adults and children 2 years of age and older with fibroblast growth factor 23 (FGF23)–related hypophosphatemia in tumor-induced osteomalacia (TIO) when the tumor cannot be located or removed.
You should not take CRYSVITA if:
What is the most important information you should know about CRYSVITA?
What are the possible side effects of CRYSVITA?
Adverse reactions that were seen in adults with TIO are:
While taking CRYSVITA, tell your doctor if you experience:
These are not all the possible side effects of CRYSVITA. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Kyowa Kirin, Inc. at 1-844-768-3544.
For important risk and use information, please see the full Prescribing Information for CRYSVITA.
Before taking CRYSVITA, tell your doctor about all of your medications (including supplements) and medical conditions, including if you:
While taking CRYSVITA, tell your doctor if you experience:
These are not all the possible side effects of CRYSVITA. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Kyowa Kirin, Inc. at 1-844-768-3544.
<<<<<<< HEADFor important risk and use information, please see the full Prescribing Information.
=======For important risk and use information, please see the full Prescribing Information for CRYSVITA.
>>>>>>> 55dcba7 (label updates feedback addressed as per the excel shared)